Symposium: Precision Medicine –  Statistical Opportunities and Challenges

Speakers from Harvard T.H. Chan School of Public Health, Harvard Medical School, Dana-Farber Cancer Institute, Pfizer, and other experts present on precision medicine at our annual biostatistics symposium. Register by April 7, 2021.

Tianxi Cai, ScD
John Rock Professor of Population and Translational Data Science
Harvard T.H. Chan School of Public Health
Professor of Biomedical Informatics, Harvard Medical School
Precision Medicine with Imprecise Data

Sandra Lee, ScD
Assistant Professor, Department of Data Science, Dana-Farber Cancer Institute
Assistant Professor, Department of Biostatistics, Harvard T.H. Chan School of Public Health
Collaborative Modeling of Precision Screening in Breast Cancer

Sandeep Menon, PhD
Senior Vice President and the Head of Early Clinical Development, Pfizer Inc.
Adjunct Professor of Biostatistics, Boston University
Considerations for Biomarker-Led Innovative Clinical Trial Designs

Giovanni Parmigiani, PhD
Professor, Department of Biostatistics, Harvard T.H. Chan School of Public Health
Professor, Department of Data Science, Dana-Farber Cancer Institute
Validation and Replicability of Prediction Algorithms in Oncology

Tianchen Qian, PhD
Assistant Professor, Department of Statistics, UC Irvine Donald Bren School of Information and Computer Sciences
Precision Mobile Health and Micro-Randomized Trials

John Quackenbush, PhD
Henry Pickering Walcott Professor of Computational Biology and Bioinformatics and Chair, Department of Biostatistics, Harvard T.H. Chan School of Public Health
Using Networks to Link Genotype to Phenotype

Lee-Jen (LJ) Wei, PhD
Professor, Department of Biostatistics, Harvard T.H. Chan School of Public Health
Symposium Discussant Comments